Skip to main content
. 2022 Feb 24;12(2):32. doi: 10.1038/s41408-022-00629-1

Fig. 3. Analysis of CAR transgene levels in patients with and without MNTs in CARTITUDE-1.

Fig. 3

Predicted values are shown for A Cmax, B AUC0–28d, and C Tmax. AUC0–28d area under the CAR transgene systemic level-time curve from the first dose to Day 28, CAR chimeric antigen receptor, Cmax maximum CAR transgene systemic level, gDNA genomic DNA, MNTs movement and neurocognitive treatment-emergent adverse events, Tmax time of maximum cilta-cel transgene expansion.